BE826498A - Composition therapeutique solide a usage interne - Google Patents

Composition therapeutique solide a usage interne

Info

Publication number
BE826498A
BE826498A BE154189A BE154189A BE826498A BE 826498 A BE826498 A BE 826498A BE 154189 A BE154189 A BE 154189A BE 154189 A BE154189 A BE 154189A BE 826498 A BE826498 A BE 826498A
Authority
BE
Belgium
Prior art keywords
therapeutic composition
internal use
solid therapeutic
solid
internal
Prior art date
Application number
BE154189A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE826498A publication Critical patent/BE826498A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE154189A 1974-03-12 1975-03-10 Composition therapeutique solide a usage interne BE826498A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (fr) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
BE826498A true BE826498A (fr) 1975-06-30

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
BE154189A BE826498A (fr) 1974-03-12 1975-03-10 Composition therapeutique solide a usage interne

Country Status (12)

Country Link
US (1) US3976764A (fr)
JP (1) JPS5512411B2 (fr)
BE (1) BE826498A (fr)
CA (1) CA1054056A (fr)
CH (1) CH604719A5 (fr)
DE (1) DE2510620C2 (fr)
DK (1) DK142802B (fr)
ES (1) ES435500A1 (fr)
FR (1) FR2263744B1 (fr)
GB (1) GB1507521A (fr)
NL (1) NL7502952A (fr)
SE (1) SE409286B (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
JPS58501128A (ja) * 1981-07-15 1983-07-14 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 徐放性テオフイリン
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (fr) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
WO1992000066A1 (fr) * 1990-06-25 1992-01-09 The Du Pont Merck Pharmaceutical Company Suspension d'hydrochlorure d'amantadine possedant des caracteristiques de dissolution ameliorees, utilisee dans la preparation de capsules de gelatine souples
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
EP1063973B1 (fr) 1998-03-19 2016-11-16 Bristol-Myers Squibb Company Systeme d'apport a liberation lente biphasique destine a des medicaments a solubilite elevee et procede associe
EP1245227A1 (fr) * 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
EA011215B1 (ru) * 2003-02-21 2009-02-27 Лек Фармасьютиклз Д.Д. Терапевтическая система, содержащая амоксициллин и клавулановую кислоту, плавающая капсула
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
CA2661172A1 (fr) * 2006-09-04 2008-05-29 Panacea Biotec Limited Technique de liberation programmable par systeme flottant
WO2009087665A2 (fr) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Nouveau système d'administration de médicament à rétention gastrique
GB2460915B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
EP2329810A4 (fr) * 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science Système d'administration de médicament à rétention gastrique, procédé de préparation et son utilisation
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
CA2767143A1 (fr) * 2009-07-06 2011-01-13 Kyorin Pharmaceutical Co., Ltd. Comprime ayant une structure creuse
CA2803064C (fr) 2010-07-05 2017-12-19 Jagotec Ag Forme posologique
WO2014014348A1 (fr) * 2012-07-16 2014-01-23 APET Holding B.V. Système d'administration pharmacologique à rétention gastrique
CA2841731A1 (fr) * 2011-07-14 2013-01-17 Hendrik Jan Cornelis Meijerink Compositions de nicotinamide et leur utilisation therapeutique
CA2851765C (fr) 2011-10-11 2017-08-15 Ranbaxy Laboratories Limited Systeme de dosage de retention gastrique et procede de preparation de celui-ci
ES2536836T3 (es) 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
WO2015191922A1 (fr) 2014-06-11 2015-12-17 Massachusetts Institute Of Technology Élastomères entériques
EP3034070A1 (fr) 2014-12-18 2016-06-22 Omya International AG Procédé pour la production d'un système d'administration pharmaceutique
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
EP3069713A1 (fr) 2015-03-20 2016-09-21 Omya International AG Forme posologique dispersible
CA2983272C (fr) 2015-05-01 2023-08-29 Massachusetts Institute Of Technology Dispositifs d'induction a memoire de forme pouvant etre declenches
HK1258050A1 (zh) 2015-10-23 2019-11-01 Lyndra Therapeutics, Inc. 用於治疗剂缓释的胃驻留系统及其使用方法
EP3386488B1 (fr) 2015-12-08 2023-09-06 Lyndra Therapeutics, Inc. Configurations géométriques de systèmes à résidence gastrique
AU2017235598A1 (en) * 2016-03-18 2018-08-09 Grünenthal GmbH Floating pharmaceutical dosage form
AU2017268840B2 (en) 2016-05-27 2022-02-10 Nortiva Bio, Inc. Materials architecture for gastric residence systems
EP3269361A1 (fr) 2016-07-14 2018-01-17 Omya International AG Forme posologique
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
JP7624750B2 (ja) * 2020-03-02 2025-01-31 クラフト ヘルス プライベート リミテッド 持続的薬物放出のための経口剤形
EP4008509B1 (fr) * 2020-10-14 2023-06-07 Bichsel, Hannes Grains biogranulaires expansés
WO2023166225A1 (fr) * 2022-03-04 2023-09-07 APET Holding B.V. Formulations d'enzyme digestive

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
JPS5512411B2 (fr) 1980-04-02
ES435500A1 (es) 1977-02-01
US3976764A (en) 1976-08-24
DE2510620C2 (de) 1984-01-05
DK97875A (fr) 1975-09-13
FR2263744A1 (fr) 1975-10-10
CA1054056A (fr) 1979-05-08
DK142802B (da) 1981-02-02
CH604719A5 (fr) 1978-09-15
SE409286B (sv) 1979-08-13
FR2263744B1 (fr) 1978-11-24
GB1507521A (en) 1978-04-19
SE7502725L (fr) 1975-09-15
DK142802C (fr) 1981-09-21
DE2510620A1 (de) 1975-09-18
NL7502952A (nl) 1975-09-16
JPS50121418A (fr) 1975-09-23

Similar Documents

Publication Publication Date Title
BE826498A (fr) Composition therapeutique solide a usage interne
MX162719A (es) Mejoras a plataforma de cosechadora
BE830343R (fr) Garnitures absorbantes a jeter apres usage
FR2329417A1 (fr) Instrument rotatif a moteur
FR2315985A1 (fr) Melangeur rotatif interne
SE7511711L (sv) Roterande forbrenningsmotor
DK268875A (da) Akkumulator med viklede elektroder
IT1048641B (it) Pila a combustibile perfezionata
BE855919Q (fr) Sel de lysine a action therapeutique
RO72528A (fr) Procede de preparation du chlorhydrate de 6-dezoxy-5-hydroxytetracycline
BR7505101A (pt) Pilha a combustivel aperfeicoada
DK397975A (da) Overladet forbrendingsmotor
FR2291737A1 (fr) Compresse a usage medical
FR2288718A1 (fr) Composition refractaire a durcissement rapide
IT1043192B (it) Pila a combustibile perfezionata
MX146757A (es) Mejoras a composicion dentifrica
FR2280514A1 (fr) Duplicateur rotatif
FR2290165A1 (fr) Composition a fumer
FR2284043A1 (fr) Carburateur a starter perfectionne
BE833906A (fr) Compositions pharmaceutiques comprenant des canadensolides propres a la guerison des ulceres
BE826797A (fr) Perfectionnements relatifs a des trepans
IT1040438B (it) Perfezionamenti relativi a composizioni leganti
FR2281230A1 (fr) Duplicateur rotatif
ZA753285B (en) Angular position transducers for use in engine timing controls
ZA752041B (en) Improvements relating to pharmaceutical compositions with an antiulcus activity

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EISAI CO. LTD

Effective date: 19930331